Statistics
Publications
59
Citations
1.8K
H-Index
26
Active since
2007
Lingling Feng is an author at Central China Normal University specializing in drug discovery, pharmacy, and medicinal chemistry.
Publications per year
2007–2024
59
59
Structural basis of the therapeutic anti-PD-L1 antibody atezolizumab
Fei Zhang, Xiaoqiang Qi, Xiaoxiao Wang et al. · Oncotarget · 2017 · 82 citations · Full text
A pancreatic cancer organoid platform identifies an inhibitor specific to mutant KRAS
Xiaohua Duan, Tuo Zhang, Lingling Feng et al. · Cell stem cell · 2023 · 72 citations · Full text
Medicine, Cancer Biology, Oncology +13
1–5 of 59